© 2001 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo
aDepartment of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
bLife Science Institute, Asahi Chemical Co., Shizuoka, Japan
cNara Institute of Science and Technology, Ikoma, Japan
* Corresponding author. Tel.: +81-92-642-5360; fax: +81-92-642-5374 shimo{at}cardiol.med.kyushu-u.ac.jp
Objective: We recently demonstrated that Rho-kinase/ROK/ROCK is functionally upregulated at the arteriosclerotic coronary lesions and plays a key role for coronary vasospastic responses in our porcine model with interleukin (IL)-1β. In the present study, we tested our hypothesis that Rho-kinase is involved in the pathogenesis of coronary arteriosclerosis per se in our porcine model. Methods: Segments of the left porcine coronary artery were chronically treated from the adventitia with IL-1β. Two weeks after the procedure, coronary stenotic lesions with constrictive remodeling and vasospastic response to serotonin were noted at the IL-1β-treated site, as previously reported. Then, animals were randomly divided into two groups; one group was treated with fasudil for 8 weeks followed by 1 or 4 weeks of washout period and another group served as a control. After oral absorption, fasudil is metabolized to hydroxyfasudil that is a specific inhibitor of Rho-kinase. Results: In the fasudil group, coronary stenosis and vasospastic response were progressively reduced in vivo, while the coronary hyperreactivity was abolished both in vivo and in vitro. Furthermore, Western blot analysis showed that in the fasudil group, the Rho-kinase activity (as evaluated by the extent of phosphorylation of myosin binding subunit of myosin phosphatase, one of the major substrates of Rho-kinase) was significantly reduced, while histological examination demonstrated a marked regression of the coronary constrictive remodeling. Conclusions: These results indicate that Rho-kinase is substantially involved in constrictive remodeling and vasospastic activity of the arteriosclerotic coronary artery, both of which could be reversed by long-term inhibition of the molecule in vivo. Thus, Rho-kinase may be regarded as a novel therapeutic target for arteriosclerotic vascular disease.
KEYWORDS Atherosclerosis; Cytokines; G-proteins; Remodeling; Signal transduction
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Greif, A. Becker, F. von Ziegler, C. Lebherz, M. Lehrke, U. C. Broedl, J. Tittus, K. Parhofer, C. Becker, M. Reiser, et al. Pericardial Adipose Tissue Determined by Dual Source CT Is a Risk Factor for Coronary Atherosclerosis Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 781 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Soliman, G. P. Craig, P. Nagareddy, V. G. Yuen, G. Lin, U. Kumar, J. H. McNeill, and K. M. MacLeod Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats Cardiovasc Res, July 15, 2008; 79(2): 322 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Nuno, V. P. Korovkina, S. K. England, and K. G. Lamping RhoA Activation Contributes to Sex Differences in Vascular Contractions Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 1934 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Noma, C. Goto, K. Nishioka, K. Hara, M. Kimura, T. Umemura, D. Jitsuiki, K. Nakagawa, T. Oshima, K. Chayama, et al. Smoking, Endothelial Function, and Rho-Kinase in Humans Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2630 - 2635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Shimokawa and A. Takeshita Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1767 - 1775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nakayama, M. Amano, A. Katsumi, T. Kaneko, S. Kawabata, M. Takefuji, and K. Kaibuchi Rho-kinase and myosin II activities are required for cell type and environment specific migration Genes Cells, February 1, 2005; 10(2): 107 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wolfrum, A. Dendorfer, Y. Rikitake, T. J. Stalker, Y. Gong, R. Scalia, P. Dominiak, and J. K. Liao Inhibition of Rho-Kinase Leads to Rapid Activation of Phosphatidylinositol 3-Kinase/Protein Kinase Akt and Cardiovascular Protection Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1842 - 1847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kawamura, K. Yokote, S. Asaumi, K. Kobayashi, M. Fujimoto, Y. Maezawa, Y. Saito, and S. Mori High Glucose-Induced Upregulation of Osteopontin Is Mediated via Rho/Rho Kinase Pathway in Cultured Rat Aortic Smooth Muscle Cells Arterioscler Thromb Vasc Biol, February 1, 2004; 24(2): 276 - 281. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Hattori, H. Shimokawa, M. Higashi, J. Hiroki, Y. Mukai, K. Kaibuchi, and A. Takeshita Long-Term Treatment With a Specific Rho-Kinase Inhibitor Suppresses Cardiac Allograft Vasculopathy in Mice Circ. Res., January 9, 2004; 94(1): 46 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-C. Tosello-Trampont, K. Nakada-Tsukui, and K. S. Ravichandran Engulfment of Apoptotic Cells Is Negatively Regulated by Rho-mediated Signaling J. Biol. Chem., December 12, 2003; 278(50): 49911 - 49919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kandabashi, H. Shimokawa, K. Miyata, I. Kunihiro, Y. Eto, K. Morishige, Y. Matsumoto, K. Obara, K. Nakayama, S. Takahashi, et al. Evidence for Protein Kinase C-Mediated Activation of Rho- Kinase in a Porcine Model of Coronary Artery Spasm Arterioscler Thromb Vasc Biol, December 1, 2003; 23(12): 2209 - 2214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Mallat, A. Gojova, V. Sauzeau, V. Brun, J.-S. Silvestre, B. Esposito, R. Merval, H. Groux, G. Loirand, and A. Tedgui Rho-Associated Protein Kinase Contributes to Early Atherosclerotic Lesion Formation in Mice Circ. Res., October 31, 2003; 93(9): 884 - 888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. SOMLYO and A. V. SOMLYO Ca2+ Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase Physiol Rev, October 1, 2003; 83(4): 1325 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Noma, Y. Higashi, D. Jitsuiki, K. Hara, M. Kimura, K. Nakagawa, C. Goto, T. Oshima, M. Yoshizumi, and K. Chayama Smoking Activates Rho-Kinase in Smooth Muscle Cells of Forearm Vasculature in Humans Hypertension, May 1, 2003; 41(5): 1102 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Lamping Enhanced Contractile Mechanisms in Vasospasm: Is Endothelial Dysfunction the Whole Story? Circulation, April 2, 2002; 105(13): 1520 - 1522. [Full Text] [PDF]
|
|
|
|
|
|
T. Kandabashi, H. Shimokawa, Y. Mukai, T. Matoba, I. Kunihiro, K. Morikawa, M. Ito, S. Takahashi, K. Kaibuchi, and A. Takeshita Involvement of Rho-Kinase in Agonists-Induced Contractions of Arteriosclerotic Human Arteries Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 243 - 248. [Abstract] [Full Text] [PDF]
|
|